Medical products maker Baxter International said on Monday its CEO José Almeida will retire effective immediately, after ...

Baxter International’s longtime CEO and board chair, José Almeida, is stepping down and retiring, effective immediately, the ...

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

Baxter International announced Monday that its CEO ... but Almeida said in the release, “With the key elements of our broad strategic transformation complete, this is the right time for a ...

I critique Baxter International's capital allocation decisions, stating the stock is not suitable for popular investment strategies. See why I rate BAX a sell.